Single Ascending Dose (BMS-813160) Study

NCT01049165 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Accelerated Intimal Hyperplasia

Interventions

DRUG: BMS-813160
DRUG: BMS-813160
DRUG: BMS-813160
DRUG: BMS-813160
DRUG: BMS-813160
DRUG: BMS-813160
DRUG: [14C] BMS-813160
DRUG: Placebo
DRUG: BMS-813160
DRUG: BMS-813160

Sponsor

Bristol-Myers Squibb